BWXT Medical submits Tc-99m generator application to FDA

September 14, 2022, 3:02PMNuclear News

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.

To continue reading, log in or create a free account!

Related Articles

Young Members Group shines at YPC

January 9, 2024, 4:48PMNuclear News

A big thank-you to the American Nuclear Society Young Members Group for all it accomplished at the Young Professionals Congress (YPC) and President’s Special Session at the 2023 ANS Winter...

National lab partnerships speed nuclear deployment

December 15, 2023, 4:56PMNuclear NewsDonna Kemp Spangler and Joel Hiller

“The tools of the academic designer are a piece of paper and a pencil with an eraser. If a mistake is made, it can always be erased and changed. If the practical-reactor designer errs, he...